相关实验视频

Updated: Jan 12, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

免疫疗法治疗转移性黑色素瘤的有效性:一项随机对照试验

Maariyah Arsheen¹, Madhavi Khokhar², Vikesh Kumar R Shah³

¹MBBS Graduate, Ayaan Institute of Medical Sciences, Teaching Hospital and Research Centre, Telangana, India.

Journal of pharmacy & bioallied sciences

|October 30, 2025

概括

与化疗相比,免疫疗法显著改善了转移性黑色素瘤患者的生存率. 这种先进的治疗方法提供了更好的结果与可控的副作用,彻底改变了癌症护理.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

转移性黑色素瘤的治疗已经被免疫疗法彻底改变.
检查点抑制剂 (例如PD-1/PD-L1) 在癌症治疗中显示出有效性.
转移性黑色素瘤的标准治疗通常涉及化疗.

研究的目的:

评估免疫疗法与转移性黑色素瘤患者的标准护理之间的疗效.
为了比较治疗组之间的无进展生存期 (PFS) 和整体生存期 (OS).
评估与免疫疗法相关的免疫相关不良事件.

主要方法:

进行了一项随机对照试验.
晚期转移性黑色素瘤患者被分配给免疫疗法或化疗.
关键参数包括PFS,OS和不良事件;统计学意义为P<0.05.

主要成果:

与化疗相比,免疫疗法显著改善了PFS和OS (P < 0.01).
副作用是可以管理的,并且与已知的检查点抑制剂配置文件保持一致.
在不良事件概况中没有发现显著差异.

结论:

免疫疗法是转移性黑色素瘤的优越选择,改善了生存率.
治疗提供可控的毒性,提高患者的治疗结果.
进一步的研究应侧重于患者选择和组合疗法.

关键词:

检查点抑制剂检查点抑制剂免疫疗法免疫疗法发生转移的黑色素瘤.总体存活率总体存活率随机对照试验是随机对照试验.

更多相关视频

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs

Published on: May 24, 2016

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.